sameAs
Transdermal drug delivery: problems and possibilitiesNanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitisTherapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formatioEndothelial cells as therapeutic targets in cancer: new biology and novel delivery systems.Niosomes as Nano-Delivery Systems in the Pharmaceutical Field.Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy.Antibodies and peptides in cancer therapy.Reviewing biophysical and cell biological methodologies in cell-penetrating peptide (CPP) research.Transdermal iontophoresis: impact on skin integrity as evaluated by various methods.Formulation, stability, and delivery of live attenuated vaccines for human use.Enhancement of ocular drug penetration.Transdermal and transmucosal powdered drug delivery.Phase-transition polymers for drug delivery.Dental drug-delivery devices: local and sustained-release applications.Microemulsions: an overview and pharmaceutical applications.Electroporation therapy of solid tumors.Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy.Gene-delivery systems using cationic polymers.Targeted delivery of radiolabeled imaging and therapeutic agents: bifunctional radiopharmaceuticals.Drug-polymer conjugates containing acid-cleavable bonds.Polyrotaxanes: synthesis, structure, and potential in drug delivery.The use and development of retroviral vectors to deliver cytokine genes for cancer therapy.Fast-dissolve drug delivery systems.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicOral delivery of HIV-protease inhibitors.Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review.Water-structuring technology with the molecular chaperone proteins: indicated application of the α-crystallin domains and imidazole-containing peptidomimetics in cosmetic skin care systems or dermatological therapeutic drug carrier formulations.New approaches to antigen delivery.Drug delivery systems for the treatment of restenosis.Chirality and its implications in transdermal drug development.Polysaccharides for vascular cell targeting.Targeted gene delivery: a two-pronged approach.Drug targeting by surface cationization.Regional variation in oral mucosal drug permeability.Drug delivery by the intravaginal route.Site-specific drug delivery in the gastrointestinal tract.Enhancement of transdermal drug delivery: chemical and physical approaches.Liposomal formulations of Cyclosporin A: a biophysical approach to pharmacokinetics and pharmacodynamics.Preparation of drug delivery systems using supercritical fluid technology.
P1433
Q26343509-F5436DC9-4491-4712-A0A6-E6D7EC428781Q28086953-9E781564-A246-40A6-ACD8-A3256E128E8AQ30389443-A789A9EC-D0F2-440C-BE33-F45FB5D30081Q31019427-AE938BB1-E495-4430-A54A-F856F75D0A9BQ31132050-B5B50A37-6664-481D-BDCE-35DEE24C09D8Q31158541-13F647D2-D983-4D14-AE25-15A21C043421Q33268409-A15C5CBA-3CA6-4503-B03E-45C2266B3E9BQ33281676-C28CC5B8-4266-4C37-8EAE-2C94C9D0D083Q33303592-240944B8-A1CC-4337-8996-10D2EA0F5628Q33341455-ED56404B-AB5D-4BC8-8D42-08DCD0E7FC57Q33547350-38DEA00F-B658-4BBF-8529-8D52A7388BA0Q33547352-B0C9E8BD-4B17-426B-A8C4-47856B9A912CQ33757682-33130CC6-A051-4931-B9D6-DA8E7551757EQ33757684-85646492-B5E1-4E31-B0DB-5D7EE181F7B1Q33817684-4BE9B0B5-18B8-4CA7-A324-1CF88CEF57BAQ33817689-771FCF62-71C7-4EEF-96AF-092A31D7688CQ33839516-51341564-6D27-4F79-82E4-4F108FC04BDEQ33839522-E1DF3771-CB4F-4D29-AC6A-1380957863E9Q33856312-D3735E72-2758-4190-84FC-F335964C0FDFQ33856317-5BBEA0BC-BE3B-4F70-A621-C83CD8ADFDA5Q33856370-387C3152-6E46-441F-8D3F-52F243175624Q33856377-DB03E22D-3878-4666-87F7-B4D9F1E2E2EBQ33885856-C0478E7E-EB5A-4B63-AB66-6D114FCCF657Q33885861-6BCB34EF-A2D4-4C7D-B13C-228B99368BF7Q33911056-2E2D39F7-DE0C-429B-8F26-28FF4C408403Q33924178-CDB6F7DE-7369-4C17-9612-B4304BBE6C5CQ33924183-3F0884B2-3E0E-463E-8FCF-2E0844E0C5F1Q33929487-59D96D84-9DD9-468C-B3B2-DCA8D1B1EC30Q33951038-49BE4072-6B93-4DFB-8224-3DD40C9A7000Q33951045-F862D1BE-CEFB-43A6-84BB-D6C756316718Q34013412-A77B7181-7CAB-4729-AFA0-F39C88DDFB4CQ34013417-DCDC3210-FCA6-494A-87AA-AC24D06BDFF9Q34013423-E5609394-5DFC-4A8A-9CB5-82365016D707Q34099715-497DF0A4-A053-4A78-961B-4CD91AE6C35BQ34099720-94D93D71-30D9-4A41-AFFC-51168641D108Q34099726-CA5420D2-56F5-44EF-8A0D-1EFAE39CB2D1Q34154903-6D055770-BEFA-4661-80B7-58A81ED215E3Q34154908-9C9ED4CC-07B2-4688-8F00-937A54DEFF8FQ34233674-A64B2335-E553-481A-80E1-7B8DA73D0A7DQ34233686-5964AEEC-0D64-4590-93AB-B691969FA887
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Begell House
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Critical Reviews in Therapeutic Drug Carrier Systems
@ast
Critical Reviews in Therapeutic Drug Carrier Systems
@da
Critical Reviews in Therapeutic Drug Carrier Systems
@de
Critical Reviews in Therapeutic Drug Carrier Systems
@en
Critical Reviews in Therapeutic Drug Carrier Systems
@es
Critical Reviews in Therapeutic Drug Carrier Systems
@fi
Critical Reviews in Therapeutic Drug Carrier Systems
@fr
Critical Reviews in Therapeutic Drug Carrier Systems
@it
Critical Reviews in Therapeutic Drug Carrier Systems
@nb
Critical Reviews in Therapeutic Drug Carrier Systems
@nl
type
label
Critical Reviews in Therapeutic Drug Carrier Systems
@ast
Critical Reviews in Therapeutic Drug Carrier Systems
@da
Critical Reviews in Therapeutic Drug Carrier Systems
@de
Critical Reviews in Therapeutic Drug Carrier Systems
@en
Critical Reviews in Therapeutic Drug Carrier Systems
@es
Critical Reviews in Therapeutic Drug Carrier Systems
@fi
Critical Reviews in Therapeutic Drug Carrier Systems
@fr
Critical Reviews in Therapeutic Drug Carrier Systems
@it
Critical Reviews in Therapeutic Drug Carrier Systems
@nb
Critical Reviews in Therapeutic Drug Carrier Systems
@nl
prefLabel
Critical Reviews in Therapeutic Drug Carrier Systems
@ast
Critical Reviews in Therapeutic Drug Carrier Systems
@da
Critical Reviews in Therapeutic Drug Carrier Systems
@de
Critical Reviews in Therapeutic Drug Carrier Systems
@en
Critical Reviews in Therapeutic Drug Carrier Systems
@es
Critical Reviews in Therapeutic Drug Carrier Systems
@fi
Critical Reviews in Therapeutic Drug Carrier Systems
@fr
Critical Reviews in Therapeutic Drug Carrier Systems
@it
Critical Reviews in Therapeutic Drug Carrier Systems
@nb
Critical Reviews in Therapeutic Drug Carrier Systems
@nl
P3181
P1055
P1058
P1156
P123
P1277
P1476
Critical Reviews in Therapeutic Drug Carrier Systems
@en